Caroline Baumal, MD

New England Eye Center, Boston, Massachusetts

Articles by Caroline Baumal, MD

Take-Home Points for the Treatment of AMD and DME

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.

Unmet Needs in AMD and DME

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

Drs David A. Eichenbaum and Caroline Baumal discuss unmet needs in treating AMD and DME.

Incorporating Faricimab in Clinical Practice

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

Retina specialists discuss how to incorporate faricimab into clinical practice and discuss implacations of the TRUCKEE study.

MOA of Faricimab and 2-Year Data Review

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

David A. Eichenbaum, MD, FASRS, and Caroline Baumal, MD, review the dual mechanism of action of faricimab as well as the 2-year update in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials.

Implications of Treat-and-Extend With Faricimab in AMD

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

Drs David A. Eichenbaum and Caroline Baumal discuss implications of the treat-and-extend approach with faricimab in patients with wet AMD.

AMD and DME: Factors Affecting Treatment Selection and the Importance of Shared Decision-Making

ByDavid A. Eichenbaum, MD, FASRS,Caroline Baumal, MD

August 30th 2022

Retina specialists discuss which factors impact treatment selection and how to incorporate shared decision-making into treatment selection when treating patients with AMD and DME.